PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2003 | 08 | 1 |

Tytuł artykułu

Lysosomal high molecular weight multienzyme complex

Warianty tytułu

Języki publikacji

EN

Abstrakty

EN
Three acidic glycosidases: β-galactosidase (β-GAL, EC 3.2.1.23), α-neuraminidase (NEUR, sialidase, EC 3.2.1.18), N-acetylaminogalacto-6-sulfate sulfatase (GALNS, EC 3.1.6.4) and serine carboxypepidase cathepsin A (EC 3.4.16.1) form a functional high molecular weight complex in the lysosomes. The major constituent of this complex is cathepsin A, the so-called “lysosomal protective protein” (PPCA). By forming a multienzyme complex, it protects the glycosidases from rapid intralysosomal proteolysis, and it is also required for the intracellular sorting and proteolytic processing of their precursors. In man, a deficiency of cathepsin A leads to a combined deficiency of β-GAL and NEUR activities, called “galactosialidosis”. Multiple mutations identified in the cathepsin A gene are the molecular basis of this lysosomal storage disease. This review describes the structural organization of the lysosomal high molecular weight multienzyme complex and the importance of the protective protein/cathepsin A in physiology and pathology.

Wydawca

-

Rocznik

Tom

08

Numer

1

Opis fizyczny

p.19-24

Twórcy

autor
  • Medical Academy of Bialystok, Bialystok, Poland
autor
autor

Bibliografia

  • 1.Pillay, C.S., Elliott, E. and Dennison, C. Endolysosomal proteolysis and its regulation. Biochem. J. 363 (2002) 417-429.
  • 2.d’Azzo, A, Andria, G., Strisciuglio, P. and Galjijaard, H. Galactosialidosis. In: The Metabolic and Molecular Bases of Inherited Disease vol. 2 (1995) 2835-2837.
  • 3.Pshezhetsky, A.V. and Ashmarina, M. Lysosomal multienzyme complex: biochemistry, genetics and molecular pathophysiology. Prog. Nucleic Acid Res. Mol. Biol. 69 (2001) 81-114.
  • 4.Hoogeveen, A.T., Verheijen, F.W. and Galjaard, H. The relation between human lysosomal β-galactosidase and its protective protein. J. Biol. Chem. 258 (1983) 12143-12146.
  • 5.Verheijen, F.W., Palmeri S., Hoogeveen, A.T. and Galjaard, H. Human placenta neuraminidase: activation, stabilization and association with β-galactosidase and its protective protein. Eur. J. Biochem. 149 (1985) 315- 321.
  • 6.Tranchemontagne, J., Michaud, L. and Potier, M. Deficient lysosomal carboxypeptidase activity in galactosialidosis. Biochem. Biophys. Res. Commun. 168 (1990) 22-29.
  • 7.Galjart, N.J., Morreau, H., Willemsen, R., Gillemans, N., Bonten, E.J. and D'Azzo, A. Human lysosomal protective protein has cathepsin A-like activity distinct from its protective function. J. Biol. Chem. 266 (1991) 14754-14762.
  • 8.Jackman, H.J., Tan, F., Tamei, H., Beurling-Harbury C., Li X.-Y., Skidgel, R.A. and Erdos, E.G. A deamidase in human platelets that deamidates tachykinins: probable identity with the lysosomal 'protective protein'. J. Biol. Chem. 265 (1990) 11265-11272.
  • 9.Hinek, A. Biological roles of the non-integrin elastin/laminin receptor. Biol. Chem. 377 (1996) 471-480.
  • 10.Morreau, H., Galjart, N.J., Willemsen, R., Gillemans, N., Zhou, X.Y. and D'Azzo, A. Human lysosomal protective protein glycosylation, intracellular transport and association with β-galactosidase in the endoplasmic reticulum. J. Biol. Chem. 267 (1992) 17949-17956.
  • 11.Rudenko, G., Bonten, E, d’Azzo, A. and Hoi, W.G.J. Three-demensional structure of the human protective protein: structure of the precursor form suggests a complex activation mechanism. Current Biol. 3 (1995) 1249- 1259.
  • 12.Bonten, E. J. and d’Azzo, A. Lysosomal neuraminidase catalytic activation in insect cells is controlled by the protective protein/cathepsin A. J. Biol. Chem. 275 (2000) 37657-37663.
  • 13.Hiraiwa, M. Cathepsin A/protective protein: an unsual lysosomal multifunctional protein. Cell. Mol. Life Sci. 56 (1999) 894-907.
  • 14.d’Azzo, A, Hoogeveen, A.T., Reuser, J.J., Robinson, H. and Galjaard, H. Molecular defect in combined β-galactosidase and neuraminidase deficiency in man. Proc. Natl. Acad. Sci. USA 79 (1982) 4535-4539.
  • 15.Rudenko, G., Bonten, E., Hoi, W.G.J., and D'Azzo, A. The atomic model of the human protective protein/cathepsin A. Proc. Natl. Acad. Sci. USA. 95 (1998) 621-625.
  • 16.Zhou, X.Y., Galjart, N.J., Willemsen, R., Gillemans, N., Galjaard, H. and d’Azzo, A. A mutation in a mild form of galactosialidosis impairs dimerization of protective protein and renders it unstable. EMBO J. 10 (1998) 4041-4048.
  • 17.Zhou, X.H., Morreau, H., Rottier R., Davis, D., Bonten, E., Gillemans, N., Wenger, D., Grosveld, F.G., Doherty, P., Suzuki, K. et.al. Mouse model for the lysosomal disorder galactosialidosis and correction of the phenotype with overexpressing erythroid precursor cells. Genes Dev. 9 (1995) 2623- 2634.
  • 18. Hahn, C.N., Del Pilar, M., Zhou, X.Y., Mann, L.W. and d’Azzo, A. Correction of murine galactosialidosis by bone marrow-derived macrophages overexpressing human protective protein/cathepsin A under control of the colony-stimulating factor-1 receptor promoter. Proc. Natl. Acad. Sci. USA 95 (1998) 14880-14885.
  • 19. Skidel, R.A. and Erdös, E.G. Cellular carboxypeptidases. Immunol. Rev. 161 (1998) 129-141.
  • 20. Itoh, K., Kase, R., Shimmoto , M., Satake, A., Sakuraba, H. and Suzuki, Y. Protective protein as an endogenous endothelin degradation enzyme in human tissues. J. Biol. Chem 270 (1995) 515-518.
  • 21. Hanna, W.L., Turbov, J.M., Jackman, H.L., and Tan, H. Dominant chymotrypsin-like esterase activity in human lymphocyte granules is mediated by the serine carboxypeptidase calle cathepsin A-like protective protein. J. Immunol. 153 (1994) 4663-4672.
  • 22. Ostrowska, H., Wójcik, C., Omura, S. and Worowski, K. Lactacystin, a specific inhibitor of the proteasome, inhibits human platelet lysosomal cathepsin A-like enzyme. Biochem. Biophys. Res. Commun. 234 (1997) 729-732.

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.agro-article-192ef19b-06b2-473c-b0c6-d7b4558e2c5d
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.